SCHEMBL28073265

SCHEMBL28073265

O=CC1CCN(C(OC(=O)Cl)c2ccccc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
ATM Q13315 1/20 0.36
LMNA P02545 3/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
CYP2D6 P10635 3/20 0.34
CHRM3 P20309 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
TP53 P04637 1/20 0.34
PKM P14618 1/20 0.34
NFKB1 P19838 1/20 0.34
THPO P40225 1/20 0.34
HIF1A Q16665 1/20 0.34
GAA P10253 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28299375 0.86 KCNA3 (0.43) ALDH1A1ATMLMNACNR1CNR2
SCHEMBL28049321 0.84 ALDH1A1 (0.40) ALDH1A1ATMLMNACNR1CNR2
SCHEMBL28026010 0.84 ALDH1A1 (0.38) ALDH1A1ATMLMNACNR1CNR2
SCHEMBL28832222 0.82 TDP1 (0.51) ALDH1A1ATMLMNAPKMTSHR
SCHEMBL28049253 0.82 LMNA (0.47) ALDH1A1ATMLMNACYP2D6CYP1A2
SCHEMBL28086157 0.82 LMNA (0.51) ALDH1A1ATMLMNACYP2D6CYP1A2
SCHEMBL27851589 0.81 L3MBTL3 (0.36) ALDH1A1LMNACNR1CNR2CYP2D6
SCHEMBL28030487 0.81 CHRM2 (0.41) ATMCHRM3HRH1CCR3KCNH2
SCHEMBL27999947 0.81 GAA (0.53) ALDH1A1LMNACYP2D6CHRM3CYP1A2
Hydrochloric Acid SCHEMBL28314858 0.81 LMNA (0.54) ALDH1A1ATMLMNACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109966294-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维爱尔兰无限公司 2019-07-05 CN disclosed
CN-109897038-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维爱尔兰无限公司 2019-06-18 CN disclosed
CN-106397418-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBVIE公司 2017-02-15 CN disclosed
CN-103167867-B Solid dispersion containing apoptosis-inducing medicament ABBVIE 公司 2016-12-21 CN disclosed
CN-103153993-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. (BS) 2016-06-01 CN disclosed
CN-105308038-A Enhancer of zeste homolog 2 inhibitors GLAXOSMITHKLINE IP NO 2 LTD 2016-02-03 CN disclosed
CN-104906100-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBOTT LAB 2015-09-16 CN disclosed
CN-104876927-A APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LAB 2015-09-02 CN disclosed
CN-102448959-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE BAHAMAS LTD 2015-06-17 CN disclosed